RecruitingNCT07644715

AI-powered ECG Analysis for Deadly Arrhythmias and ICI Myocarditis

Efficient Deep Learning Approaches for the Rapid and Interpretable Detection of Deadly Arrhythmias in ECG Data


Sponsor

Groupe Hospitalier Pitie-Salpetriere

Enrollment

127,000 participants

Start Date

Jan 1, 2026

Study Type

OBSERVATIONAL

Conditions

Summary

ELDORA is a non-interventional observational data-science study aiming to develop and validate clinical-grade artificial intelligence tools applied to electrocardiogram (ECG) data. The project will standardize heterogeneous ECGs, create the ECGInsight harmonized database, and train interpretable models for life-threatening arrhythmia risk prediction, especially Torsades-de-Pointes/long QT syndrome and immune checkpoint inhibitor (ICI)-induced myocarditis. The project uses existing and ongoing national and international ECG cohorts with de-identified clinical metadata; AI outputs are intended for research/model development and are not used to drive patient care during the study.


Eligibility

Inclusion Criteria3

  • subjects included in participating existing or ongoing ECG cohorts made available to ECGInsight
  • availability of ECG data (digital waveform or scanned/paper ECG suitable for digitization) and relevant clinical/demographic metadata
  • data use permitted by applicable ethical, regulatory, contractual and GDPR requirements.

Exclusion Criteria1

  • datasets or individual records for which required approvals, data-sharing agreements, de-identification/anonymization, or minimum ECG/metadata quality requirements are not met. No interventional study treatment is assigned.

Interested in this trial?

Get notified about updates and connect with the research team.


Locations(1)

CIC-2503

Paris, France

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT07644715


Related Trials